U.S. Metals and Mining Stock News

In December 2025, Surgery Partners, Inc. completed a US$425,000,000 offering of 7.250% senior unsecured notes due 2032 under Rule 144A and Regulation S, supported by fixed coupons and guarantees. Around the same time, the company entered a partnership with Baylor Scott & White Health to jointly own and operate a 16-bed surgical hospital in Bryan, Texas, broadening its role in high-acuity outpatient care across the College Station region. Next, we’ll examine how the Baylor Scott & White...

Earlier this month, Yara and Air Products announced they are in advanced talks to partner on low-emission ammonia projects, including a potential US$8.00–US$9.00 billion Louisiana complex and marketing of renewable ammonia from the nearly complete NEOM project in Saudi Arabia. A particularly important aspect is that Yara may acquire about a quarter of the Louisiana project’s ammonia assets and integrate the full output into its global distribution network under long-term agreements,...

Dolby Laboratories (DLB) has been quietly navigating a mixed stretch, with the stock roughly flat over the month but still down double digits this year, even as revenue and earnings continue to grow. See our latest analysis for Dolby Laboratories. At a share price of about $66.80, Dolby’s year to date share price return of negative 14.1 percent contrasts with a modestly positive three year total shareholder return of 2.7 percent. This suggests longer term momentum has softened even as...

Pilgrim's Pride (PPC) has quietly slipped about 17% year to date, even though the business remains profitable and revenue is still growing. That disconnect is exactly what makes the stock interesting. See our latest analysis for Pilgrim's Pride. Over the past year, Pilgrim's Pride has seen its share price return sag while the three year total shareholder return of nearly 100% still signals that long term investors have been well rewarded. This suggests recent weakness may reflect shifting...

Microsoft (MSFT) has pulled back roughly 7% over the past month even as its earnings growth stays solid, which is exactly the kind of setup long term investors like to examine more closely. See our latest analysis for Microsoft. That recent 7% slide in the 30 day share price return comes after a strong year to date share price return of about 14%, while the three year total shareholder return has more than doubled. This suggests long term momentum is still intact even as near term enthusiasm...

In recent days, Accenture and Palantir, Anthropic, and Snowflake have each announced new business groups with Accenture to accelerate enterprise-scale AI and data solutions across multiple regulated and data-intensive industries. By embedding thousands of AI-skilled professionals and forward deployed engineers directly with clients, these alliances position Accenture at the center of complex, large-scale AI deployments that many enterprises may struggle to execute alone. We’ll now examine...

If you are wondering whether CVS Health is still a bargain after its recent run, or if you have already missed the sweet spot, this breakdown will help you consider whether the current price makes sense. The stock has climbed about 77.0% year to date and 85.4% over the last year, even though 3 year returns are still slightly negative. This suggests the market has rapidly rewritten its expectations for CVS after a long stretch of underperformance. Recently, investors have been evaluating CVS...

REV Group, Inc. has reported its fourth-quarter and full-year 2025 results, showing sales rising to US$664.4 million and US$2,463.5 million respectively, while net income and earnings per share from continuing operations fell sharply from the prior year. Alongside weaker profitability, the board maintained capital returns by declaring a quarterly cash dividend of US$0.06 per share, signaling ongoing confidence in the business despite margin pressure. Next, we’ll examine how softer earnings...

Telesat (NasdaqGS:TSAT) has quietly turned into a strong performer, with the stock up around 73% this year and roughly 60% over the past year, even as earnings remain in the red. See our latest analysis for Telesat. At a share price of $29.11, Telesat’s 16.95% 30 day share price return and 3 year total shareholder return of 358.43% suggest investors are steadily repricing its long term potential despite recent volatility. If Telesat’s surge has you rethinking what could move next, this might...

Capital One Financial (COF) is back in the spotlight after a wave of upbeat analyst commentary arrived alongside its latest charge-off and delinquency update, giving investors fresh data to gauge credit trends and growth potential. See our latest analysis for Capital One Financial. The upbeat analyst calls and fresh credit quality data are landing against a powerful backdrop, with Capital One’s share price up a solid 35.2 percent year to date and a standout 187.9 percent three year total...

Welltower (WELL) has quietly become one of the market’s stronger long term real estate performers, with shares up about 15% over the past 3 months and roughly 50% in the past year. See our latest analysis for Welltower. That surge in momentum is hard to miss, with a roughly 15% 90 day share price return and a near 50% one year total shareholder return, suggesting investors are steadily repricing Welltower’s growth and risk profile. If Welltower’s run has you rethinking your real estate...

Diginex (DGNX) has quietly slid about 37% over the past month, even as its year to date return stays positive. That pullback is making some investors revisit the ESG software specialist’s long term story. See our latest analysis for Diginex. That steep slide contrasts sharply with Diginex’s 604% year to date share price return. This suggests momentum has cooled for now as the market reassesses both growth potential and execution risk at around $6.60 per share. If Diginex’s sharp swings have...

Sanmina Corporation recently announced a major expansion of its Energy business, including a new Houston, Texas factory focused on the US energy market that will produce medium-voltage distribution transformers, instrument transformers and switchgear, with production targeted to begin in 2027 and initial customer commitments already secured. At the same time, Sanmina revealed a collaboration with Croatia-based Končar - Electrical Industry Inc. to co-design a custom medium-voltage transformer...

Milestone Pharmaceuticals recently received U.S. Food and Drug Administration approval for CARDAMYST (etripamil) nasal spray, its first commercial product for at-home conversion of acute symptomatic paroxysmal supraventricular tachycardia (PSVT) to sinus rhythm in adults, with retail availability targeted for early 2026. This is the first new FDA-approved PSVT treatment in over 30 years and introduces a self-administered, out-of-hospital option for more than two million affected Americans,...

Earlier this month, GigaCloud Technology Inc. presented at the 14th Annual ROTH Deer Valley Event in Utah, with President Iman Schrock outlining the company’s B2B e-commerce and logistics model for institutional investors. At the same time, the company has drawn heightened attention as analysts have raised full-year earnings estimates and assigned it a top Zacks Rank, even as insider share sales continue under pre-arranged trading plans. With analysts lifting earnings forecasts and assigning...

Electronic Arts (EA) shares have quietly ground higher this year, and with the stock now around 40% up year to date, investors are asking whether the move is justified by fundamentals. See our latest analysis for Electronic Arts. That climb has not been a sudden squeeze so much as a steady rerating, with a strong 90 day share price return supporting the year to date surge, while multi year total shareholder returns show momentum has been building rather than fading. If EA’s run has you...

Harmony Biosciences Holdings (HRMY) just gave investors two fresh reasons to pay attention, encouraging Phase 3 extension data for EPX-100 in Dravet syndrome and a new EEG focused collaboration with Beacon Biosignals that sharpens its late stage trial readouts. See our latest analysis for Harmony Biosciences Holdings. Investors seem to be leaning back toward Harmony, with the recent clinical wins arriving alongside a roughly 14 percent 1 month share price return and a still negative 3 year...

Celanese Corporation recently reported that it achieved International Sustainability & Carbon Certification (ISCC) Carbon Footprint Certification for its Hostaform and Celcon POM ECO-C grades at Frankfurt, Germany, and Bishop, Texas, supported by its carbon capture and utilization investment at the Fairway Methanol joint venture in Clear Lake, Texas. This move not only extends Celanese’s leadership in lower-carbon engineering plastics, but also embeds product-level carbon transparency into...

Key Insights The considerable ownership by retail investors in Scilex Holding indicates that they collectively have a...

On December 11, 2025, OneSpaWorld Holdings director Walter Field McLallen sold 5,000 shares, shortly after the company reported third-quarter 2025 results that aligned with Wall Street expectations and highlighted operational improvements. Analyst firm Stifel reaffirmed its positive view on OneSpaWorld, emphasizing resilient demand for its spa services without reliance on heavy promotional activity, which has reinforced investor confidence in the company’s execution. With Stifel’s renewed...

lululemon athletica (LULU) has quietly staged a sharp rebound lately, with the stock climbing about 13% over the past week and roughly 21% this month after a deep year to date slide. See our latest analysis for lululemon athletica. Even after this latest pop, the 1 year total shareholder return is still deeply negative and the share price return year to date sits well below water. This suggests that the sharp rebound looks more like early momentum rebuilding than a fully healed uptrend. If...

Bausch + Lomb Corporation recently allocated a US$2.80 billion tranche of new term B loans to refinance existing facilities, lowering interest margins and pushing all the affected debt maturities out to January 15, 2031. At the same time, upbeat analyst commentary highlighting Bausch + Lomb’s ophthalmology pipeline and efficiency efforts has reinforced the potential benefits of its cleaner, longer-dated debt profile. Next, we’ll examine how this large-scale refinancing, combined with a...

TFS Financial recently reported record fiscal 2025 earnings of US$91 million, a 14.3% increase from the prior year, supported by improved net interest margins and higher mortgage and home equity originations, while also declaring a quarterly cash dividend of US$0.2825 per share that its mutual holding company chose to forgo. Director Anthony Asher’s purchase of 1,439 shares, alongside the dividend waiver by the mutual holding company, underscores internal confidence and a capital allocation...

Brookdale Senior Living (BKD) just released fresh November occupancy figures, and they are exactly the kind of update investors watch closely in this business. See our latest analysis for Brookdale Senior Living. The November occupancy gains fit neatly into Brookdale’s broader turnaround story. The latest share price is $10.49, with a year-to-date share price return of 107.31% and a 3-year total shareholder return of 278.70%. This suggests momentum is still firmly building as investors re...